Rebuilding insight into the pathophysiology of Alzheimer's disease through new blood-brain barrier models
Neural Regeneration Research · 2024-09 · 19 (9) · 1954-1960
DOI: 10.4103/1673-5374.390978 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neural Regeneration Research, online erschienen am 15.12.2023. Verfasst von Kinya Matsuo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Demenz
Abstract (Originalsprache)
The blood-brain barrier is a unique function of the microvasculature in the brain parenchyma that maintains homeostasis in the central nervous system. Blood-brain barrier breakdown is a common pathology in various neurological diseases, such as Alzheimer's disease, stroke, multiple sclerosis, and Parkinson's disease. Traditionally, it has been considered a consequence of neuroinflammation or neurodegeneration, but recent advanced imaging techniques and detailed studies in animal models show that blood-brain barrier breakdown occurs early in the disease process and may precede neuronal loss. Thus, the blood-brain barrier is attractive as a potential therapeutic target for neurological diseases that lack effective therapeutics. To elucidate the molecular mechanism underlying blood-brain barrier breakdown and translate them into therapeutic strategies for neurological diseases, there is a growing demand for experimental models of human origin that allow for functional assessments. Recently, several human induced pluripotent stem cell-derived blood-brain barrier models have been established and various in vitro blood-brain barrier models using microdevices have been proposed. Especially in the Alzheimer's disease field, the human evidence for blood-brain barrier dysfunction has been demonstrated and human induced pluripotent stem cell-derived blood-brain barrier models have suggested the putative molecular mechanisms of pathological blood-brain barrier. In this review, we summarize recent evidence of blood-brain barrier dysfunction in Alzheimer's disease from pathological analyses, imaging studies, animal models, and stem cell sources. Additionally, we discuss the potential future directions for blood-brain barrier research.
Autor:innen und Institutionen
- Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
- Department of Neurotherapeutics, Yamaguchi University, Ube, Japan.
Zitieren
APA
Matsuo, K., & Nshihara, H. (2024). Rebuilding insight into the pathophysiology of Alzheimer's disease through new blood-brain barrier models. Neural Regeneration Research, 19(9), 1954-1960. https://doi.org/10.4103/1673-5374.390978
Vancouver
Matsuo K, Nshihara H. Rebuilding insight into the pathophysiology of Alzheimer's disease through new blood-brain barrier models. Neural Regeneration Research. 2024;19(9):1954-1960. doi:10.4103/1673-5374.390978
BibTeX
@article{Matsuo2024,
author = {Matsuo, Kinya and Nshihara, Hideaki},
title = {Rebuilding insight into the pathophysiology of Alzheimer's disease through new blood-brain barrier models},
journal = {Neural Regeneration Research},
year = {2024},
volume = {19},
number = {9},
pages = {1954--1960},
doi = {10.4103/1673-5374.390978}
}
EUVIMED